BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 9195574)

  • 1. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
    Inoue T; Ishida T; Sugio K; Sugimachi K
    Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.
    Khan A; Krishna M; Baker SP; Malhothra R; Banner BF
    Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
    Mori M; Kohli A; Baker SP; Savas L; Fraire AE
    Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
    Pechet TT; Carr SR; Collins JE; Cohn HE; Farber JL
    Ann Thorac Surg; 2004 Nov; 78(5):1748-53. PubMed ID: 15511466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical indicators of malignancy of lung cancer].
    Abe S; Sukoh N; Ogura S; Isobe H
    Hokkaido Igaku Zasshi; 1994 May; 69(3):391-5. PubMed ID: 7927167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B and cystatins: evidence for a role in cancer progression.
    Sloane BF
    Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue cathepsins as tumor markers.
    Schwartz MK
    Clin Chim Acta; 1995 Jun; 237(1-2):67-78. PubMed ID: 7664480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cathepsin B--role in cancer invasion and diagnosis].
    Haczyńska H; Warwas M
    Postepy Hig Med Dosw; 1994; 48(6):729-43. PubMed ID: 7675732
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.